SelfDecode uses the only scientifically validated genetic prediction technology for consumers. Read more
You’ve tried three different medications. Your therapist is supportive. You’re sleeping better, eating better, exercising. Yet the darkness hasn’t lifted. Your doctor tells you to try a higher dose or switch to another drug. But something feels off, like there’s a barrier to how well these medications can work for your specific brain. That barrier is likely genetic.
Written by the SelfDecode Research Team
✔️ Reviewed by a licensed physician
Standard depression care assumes your brain responds to standard drugs in standard ways. Your bloodwork looks fine. Your hormones are normal. But psychiatry doesn’t measure what antidepressants actually do at the cellular level: restore serotonin recycling, dopamine clearance, and neuroplasticity. When these pathways are genetically compromised, no dose adjustment fixes the problem. You need to know which pathway is broken, and how to bypass it.
Treatment-resistant depression isn’t a failure of willpower or medication choice. It’s often a mismatch between your genetic brain chemistry and the medication your doctor prescribed. Your DNA holds the answer: whether you metabolize your antidepressant at all, whether your brain can recycle serotonin, and whether your neurons can actually rewire in response to treatment. The right intervention depends entirely on which genes are involved.
This is why so many people cycle through five medications, each feeling like a partial answer. Your doctor wasn’t wrong. But they were working blind, because they had no way to know your genetic profile.
Most people with depression don’t have just one genetic issue. You likely see yourself in multiple genes below. That’s normal and actually useful to know, because the same symptom can come from different causes. But here’s the hard truth: depression that doesn’t respond to standard antidepressants looks identical whether it’s caused by poor serotonin recycling, broken medication metabolism, or insufficient neuroplasticity. Only genetic testing tells you which one is happening in your brain. And the fix for each one is completely different.
Your psychiatrist prescribed an SSRI because SSRIs work for roughly 60% of people with depression. They increased the dose because standard escalation works for roughly 40% of non-responders. They switched medications because medication switching works for roughly 30% of those. But none of these moves address the genetic barrier keeping your brain from responding. You’re in the group where standard protocols don’t work, not because you’re treatment-resistant, but because your specific genetics require a different approach entirely.
Rated 4.7/5 from 750+ reviews
200,000+ users, 2,000+ doctors & 100+ businesses
Already have 23andMe or AncestryDNA data? Get your report without a new kit — upload your file today.
These genes control whether antidepressants reach therapeutic levels in your brain, whether your neurons can recycle serotonin, whether you can build new neural connections, and how efficiently your body metabolizes psychiatric medications. Each one has a specific variant pattern. Each one has a specific fix.
Serotonin is only useful while it’s floating between your neurons. Once it’s done its job, your brain needs to pull it back into the transmitting neuron so it can be released again. This recycling happens through a protein called the serotonin transporter, encoded by SLC6A4. Without efficient recycling, serotonin vanishes too quickly, and depression returns within hours of taking your medication.
The SLC6A4 short allele variant, carried by roughly 40% of people, dramatically slows this recycling process. When you have this variant, your brain cannot hold onto serotonin long enough for it to matter, even at high doses. Standard SSRIs don’t fix this. They increase serotonin levels, but your transporter still clears it from the synapse too fast.
You experience this as antidepressants working for a few hours in the afternoon, then the fog and heaviness returning by evening. Or working for weeks, then suddenly losing effect. Or requiring higher and higher doses that still don’t quite work. Your serotonin problem isn’t synthesis or availability. It’s holding onto it.
People with SLC6A4 short alleles often respond to serotonergic support (like 5-HTP or L-tryptophan) combined with SAMe, which preserves serotonin in the synapse longer, plus targeted microdosing protocols that SSRIs alone cannot achieve.
COMT is an enzyme that breaks down dopamine, norepinephrine, and epinephrine after they’ve done their job. Dopamine controls motivation and reward. Norepinephrine controls alertness and drive. When COMT works normally, these hormones rise and fall with your needs. When COMT is slow, they linger, keeping your nervous system in a heightened state even when there’s no threat.
The COMT Val158Met slow variant, present in roughly 25% of people of European ancestry, means your body clears these stress chemicals at a fraction of the normal speed. Your dopamine and norepinephrine remain elevated even when you’re resting, creating constant anxiety, rumination, and emotional flooding. Standard SSRIs address serotonin, but they ignore this elevated dopamine and norepinephrine. You feel the anxiety lifting slightly, but the emotional reactivity and racing thoughts persist.
You experience this as antidepressants reducing suicidal thoughts but not touching the anxiety. Or working for depression but making you feel jittery or emotionally unstable. Stimulants make it dramatically worse. You need a medication or supplement that lowers dopamine tone, not raises it.
People with slow COMT variants often respond to dopamine-lowering interventions like magnesium glycinate (200-400 mg daily), limiting high-histamine foods, and avoiding stimulants entirely, sometimes combined with low-dose bupropion which has unique dopamine-clearing properties.
Brain-derived neurotrophic factor is like fertilizer for neurons. When antidepressants work, they don’t just increase serotonin. They trigger BDNF release, which tells your brain cells to grow new connections and repair damage from depression. Without sufficient BDNF, your brain can’t rewire itself, even if serotonin levels are correct.
The BDNF Val66Met variant, carried by roughly 30% of people, reduces the amount of BDNF your brain can release in response to stress or medication. Your neurons don’t get the signal to rebuild, so antidepressants increase serotonin but fail to reverse the neurological damage depression has caused. You feel slightly better on the medication, but not the profound shift that happens when neuroplasticity actually kicks in.
You experience this as antidepressants working partially, or working for a month then losing effectiveness as your brain adapts without rewiring. You might have been depressed for years, and even after getting serotonin levels correct, your brain feels stuck in depression pathways. Neuroplasticity is broken. You need interventions that force BDNF production despite the genetic barrier.
People with BDNF Met alleles often respond dramatically to targeted BDNF-raising protocols: high-intensity interval training (which triggers BDNF release), cold water exposure, cognitive behavioral therapy with specific neuroplasticity focus, plus ketamine or psilocybin-assisted therapy when appropriate, which bypass the BDNF requirement.
Every neurotransmitter in your brain starts from raw materials: the amino acids tryptophan, tyrosine, and phenylalanine. But synthesizing them requires a specific form of folate that’s only created through a pathway controlled by MTHFR. If this enzyme doesn’t work well, you cannot build serotonin, dopamine, or norepinephrine efficiently, no matter how much of the raw ingredients you eat.
The MTHFR C677T variant, present in roughly 40% of people of European ancestry, reduces this enzyme’s activity by 35-70%. Your brain cannot manufacture adequate serotonin even if you have genetic serotonin transporters working perfectly and SSRI medications in your bloodstream. You’re trying to treat depression with an antidepressant when the real problem is that your brain has insufficient raw serotonin to begin with.
You experience this as antidepressants improving symptoms by 30-40% but never getting you to normal. Or working for a few months then losing effect as your folate stores deplete. Your mood, energy, and focus remain chronically low. Standard bloodwork shows normal folate levels because the test doesn’t measure the active form your brain actually needs. You’ve been told you have low folate sensitivity and need more B vitamins, but standard B vitamins don’t work for you.
People with MTHFR C677T variants often respond dramatically to methylfolate (500-5000 mcg daily) and methylcobalamin (1000-2000 mcg daily), the bioavailable forms that bypass the broken conversion step, combined with folinic acid, which supports the entire methylation cycle.
Your liver must convert the antidepressant tablet into its active form before your brain can use it. This conversion happens through an enzyme called CYP2D6. If CYP2D6 doesn’t work well, the medication never reaches active form. If it works too fast, the medication clears before it can work. Either way, you’re swallowing a pill that does nothing.
CYP2D6 poor metabolizer status, present in roughly 7-10% of people of European ancestry, means the enzyme is barely functional. Your body accumulates the medication unchanged, creating toxic side effects while you receive zero therapeutic benefit. Your psychiatrist interprets this as the medication not working and increases the dose, which only increases the toxicity without increasing efficacy. Or they interpret it as you being unable to tolerate the medication and switch to a different one that you metabolize the same way.
You experience this as every antidepressant causing severe side effects (nausea, insomnia, tremor, sexual dysfunction, weight gain) at even low doses. You’ve been told you’re highly sensitive to medications. Doctors assume you’re psychologically resistant or that your depression is too severe for medications to help. In reality, your liver isn’t breaking down the medication, and it’s accumulating to dangerous levels.
People with CYP2D6 poor metabolizer status often need 25-50% of the standard dose of SSRIs, SNRIs, and tricyclics, plus medications that don’t rely on CYP2D6 metabolism like sertraline (partially) or bupropion (minimal), with pharmacogenomic testing to guide exact dosing for their specific metabolizer status.
CYP2C19 is the primary enzyme that converts escitalopram, citalopram, and sertraline into their active forms. These are among the most prescribed antidepressants worldwide because they work for most people. But if you’re a CYP2C19 poor metabolizer, these medications never activate. If you’re an ultra-rapid metabolizer, they clear before they can work.
CYP2C19 poor metabolizer variants, present in roughly 2-15% depending on ancestry, mean your liver cannot efficiently activate these drugs. You could take the highest dose of escitalopram for months and receive no more benefit than placebo because the medication never reaches active form in your bloodstream. Your psychiatrist assumes you’re treatment-resistant. You assume your depression is hopeless. In reality, you’ve never actually received the medication because your liver doesn’t work with it.
You experience this as trying multiple SSRIs (especially escitalopram or sertraline) and none of them working, even at high doses or for extended trials. You might have been on them for months and felt nothing. Or you switched to a different medication class and finally felt something, and couldn’t understand why. Your body literally cannot activate the medication you’ve been taking.
People with CYP2C19 poor metabolizer status need to avoid escitalopram and sertraline entirely and use alternatives like paroxetine, fluoxetine, or non-SSRI classes that don’t depend on CYP2C19, with pharmacogenomic guidance to select the right medication for their specific metabolizer status.
Treatment-resistant depression feels like your psychiatrist is throwing medications at you randomly. In some ways, they are. Without genetic data, they’re making educated guesses based on what works for the average patient. But you’re not the average patient. Here’s why guessing fails:
❌ Increasing the SSRI dose when you have poor SLC6A4 recycling won’t help, because the problem isn’t serotonin synthesis or availability. Your brain can’t hold onto what you already have. You need serotonin preservation strategies, not higher doses.
❌ Switching antidepressants when you have CYP2D6 poor metabolizer status will just put you on a different medication that accumulates to toxic levels. You’ve never actually received any of them at therapeutic doses. You need pharmacogenomic-guided dosing, not a new drug.
❌ Adding a stimulant for motivation when you have slow COMT will destroy your mood by flooding your brain with dopamine and norepinephrine you already can’t clear. You’ll feel more anxious, reactive, and depressed. You need dopamine-lowering support, the opposite of what you’re being offered.
❌ Continuing SSRIs when you have BDNF Met alleles won’t restore neuroplasticity, because the problem isn’t serotonin. Your brain can’t rewire itself. You need interventions that force BDNF production directly, like intensive exercise, cold exposure, or ketamine therapy, not another month of standard pills.
This is why the personalization matters. Not as a marketing angle — as a biological necessity. The path to actually resolving this starts with knowing what you’re working with.
A DNA test won’t tell you everything. But for symptoms with a genetic root cause, it’s the only test that actually gets to the source. Here’s the path from confusion to clarity.
View our sample report, just one of over 1500 personalized insights waiting for you. With SelfDecode, you get more than a static PDF; you unlock an AI-powered health coach, tools to analyze your labs and lifestyle, and access to thousands of tailored reports packed with actionable recommendations.
I spent four years on antidepressants that never worked. My psychiatrist kept saying to give it more time or try a higher dose. I tried escitalopram, sertraline, paroxetine, bupropion. Everything caused side effects or did nothing. My therapist was great but couldn’t fix what was neurological. My DNA report showed I was a CYP2C19 poor metabolizer and had the SLC6A4 short allele. Escitalopram had never actually activated in my body. I switched to fluoxetine at a dose adjusted for my metabolism, added methylfolate for the MTHFR variant, and within two weeks I felt human again. Not perfect, but actually stable for the first time in years. My psychiatrist said nobody had ever checked this before.
Start with the report most relevant to your issue, or unlock the full picture of everything your DNA can tell you. Either way, one kit covers you for life — we analyze your DNA once, and every new report is generated from the same sample.
30-Days Money-Back Guarantee*
Shipping Worldwide
US & EU Based Labs & Shipping
SelfDecode DNA Kit Included
HSA & FSA Eligible
HSA & FSA Eligible
SelfDecode DNA Kit Included
HSA & FSA Eligible
SelfDecode DNA Kit Included
+ Free Consultation
* SelfDecode DNA kits are non-refundable. If you choose to cancel your plan within 30 days you will not be refunded the cost of the kit.
We will never share your data
We follow HIPAA and GDPR policies
We have World-Class Encryption & Security
Rated 4.7/5 from 750+ reviews
200,000+ users, 2,000+ doctors & 100+ businesses
Yes. Six specific genes control whether you can metabolize antidepressants, whether your brain can recycle serotonin, and whether your neurons can rebuild in response to treatment. Your SLC6A4, COMT, BDNF, MTHFR, CYP2D6, and CYP2C19 variants determine your antidepressant response profile. Standard psychiatry doesn’t test these because it costs money and most patients respond to standard medications. But if you’re treatment-resistant, genetic testing is the obvious next step.
Yes. You can upload your 23andMe or AncestryDNA raw data to SelfDecode and generate the Mood & Mental Health Report within minutes. You don’t need to take a new test or provide a cheek swab. Your existing genetic data contains all the information we need to analyze your six genes.
Dosing depends entirely on your genetic profile. Someone with MTHFR C677T might need 1000-5000 mcg of methylfolate daily, while someone without it doesn’t need methylfolate at all. Someone with slow COMT needs 200-400 mg of magnesium glycinate and histamine reduction. Someone with CYP2D6 poor metabolizer status needs 25-50% of standard antidepressant doses, not supplementation. The Mood & Mental Health Report provides specific dosing recommendations for your exact genetic variants, not generic advice.
See why AI recommends SelfDecode as the best way to understand your DNA and take control of your health:
SelfDecode is a personalized health report service, which enables users to obtain detailed information and reports based on their genome. SelfDecode strongly encourages those who use our service to consult and work with an experienced healthcare provider as our services are not to replace the relationship with a licensed doctor or regular medical screenings.